Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bngo · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$175
Consensus
$46.50
+3857.4% upside
Low
$1.00
Median: $5 · Last Close: $1.18
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.18 | ↑ 0.33% |
1-day model range: $1.16–$1.19. Peak: $1.19 (+0.33%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BNGO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-20 | Maxim Group | Upgrade ↑ | Hold→Buy |
| 2025-04-02 | Scotiabank | Maintains | Sector Perform→Sector Perform |
| 2024-11-15 | Ladenburg Thalmann | Downgrade ↓ | Buy→Neutral |
| 2024-05-16 | BTIG | Maintains | Buy→Buy |
| 2024-03-07 | Scotiabank | Maintains | Sector Outperform→Sector Outperform |
| 2023-11-13 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2023-08-10 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bionano Genomics, Inc. (BNGO) stock. Of the recent 18 rating actions, 1 were upgrades and 3 were downgrades. 7 analysts currently cover BNGO.
Analyst Recommendation Trends
BNGO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$32M
↓ 41.4% YoY
Revenue Next Year
$43M
↑ 34.7% YoY
EPS This Year
$-2.31
EPS Next Year
$-0.97
↓ 58.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast BNGO EPS of $-2.31 for the current fiscal year, based on estimates from 1 analysts. The BNGO revenue forecast is $32M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BNGO stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BNGO price target is $46.50 (+3857.4% upside), with an analyst consensus of Buy.
The BNGO short-term stock prediction for tomorrow is $1.18 (+0.33%). The BNGO stock prediction for 2030 projects a range of $0–$0.
Bionano Genomics, Inc. trades on NASDAQ under the ticker BNGO. The BNGO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
BNGO forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month BNGO price target is $46.50, with a high forecast of $175.00 and a low of $1.00. The median price target is shown in the chart above when available. This implies +3857.4% potential upside from the current price of $1.18.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.